Science Explorer Interactive view Map
Institution · Berlin · Germany

European Neuroendocrine Tumor Society

In research, European Neuroendocrine Tumor Society stands highest in Health Sciences (#10,500 of 20,462 worldwide) and Medicine (#13,416 of 17,978 worldwide), over all time.

enets.orgROR OpenAlex
World rank, 2022–2025
#26,523
of 28,054 · #28,425 all time
Rank in Germany
#1,095
of 1,178
Research works
347
▲ 16% vs 2013–17
Citations
3.7k
10.8 per fractional work
Top-10% rate
11.4%
record average 16.5%
Open access
39%
world 28%

What is European Neuroendocrine Tumor Society known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #10,500 of 20,462 11.5%236
MedicineField #13,416 of 17,978 11.9%217

Each strip is that field’s whole ranked pool, with the notch where European Neuroendocrine Tumor Society sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.18× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.71× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 1.13× its world share, 1 worksImmunology and Micro…Neuroscience: 1.14× its world share, 1 worksNeuroscienceChemistry: 0.05× its world share, 0 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEngineering: 0.06× its world share, 1 worksEngineeringEnvironmental Science: 0.13× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.10× its world share, 0 worksMaterials ScienceMathematics: 0.41× its world share, 0 worksMathematicsPhysics and Astronomy: 0.38× its world share, 1 worksPhysics and AstronomyDentistry: 0.12× its world share, 0 worksDentistryHealth Professions: 1.35× its world share, 2 worksHealth ProfessionsMedicine: 3.47× its world share, 47 worksMedicineNursing: 1.01× its world share, 0 worksNursingArts and Humanities: 1.22× its world share, 2 worksArts and HumanitiesBusiness, Management and Accounting: 0.21× its world share, 0 worksBusiness, Management…Decision Sciences: 0.25× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.33× its world share, 0 worksEconomics, Econometr…Psychology: 0.86× its world share, 2 worksPsychologySocial Sciences: 0.39× its world share, 4 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.5×. Every wedge is a field page.

Who are the top researchers at European Neuroendocrine Tumor Society?

Ranked on the composite score, Georg Crezelius and Peter Stegmaier lead among researchers whose main affiliation is European Neuroendocrine Tumor Society.

  1. 1 Georg Crezelius Germany · #292,896 worldwide 1 citations · 43 works
  2. 2 Peter Stegmaier Germany · #357,915 worldwide 4 citations · 47 works
All ranked researchers at European Neuroendocrine Tumor Society

Which keywords describe research at European Neuroendocrine Tumor Society?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Genetic Mutations, Immunotherapy, Survival Analysis, Chemotherapy, Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors, Prognostic Factors and Targeted Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Genetic Mutations13▲ 44×9 topics
  2. Immunotherapy11▲ 23×15 topics
  3. Survival Analysis11▲ 56×5 topics
  4. Chemotherapy9▲ 19×12 topics
  5. Neuroendocrine Tumors9▲ 381×1 topic
  6. Pancreatic Neuroendocrine Tumors9▲ 381×1 topic
  7. Prognostic Factors7▲ 24×12 topics
  8. Targeted Therapy6▲ 42×4 topics
  9. Clinical Trials6▲ 12×5 topics
  10. Biomarkers6▲ 11×6 topics
  11. Metastasis5▲ 21×4 topics
  12. Genomic Profiles5▲ 164×1 topic
  13. Small-Cell Lung Cancer5▲ 164×1 topic
  14. Tumor Microenvironment4▲ 12×6 topics
  15. Neoadjuvant Therapy3▲ 19×4 topics
  16. Pancreatic Cancer3▲ 38×2 topics
  17. PET Imaging3▲ 24×4 topics
  18. Therapy3▲ 20×4 topics
  19. Gemcitabine3▲ 54×1 topic
  20. Surgical Complications3▲ 48×1 topic
  21. Staging System2▲ 56×2 topics
  22. Cancer2▲ 2.4×13 topics
  23. Prognosis2▲ 10×4 topics
  24. Treatment2▲ 2.7×11 topics
  25. Genomic2▲ 75×2 topics
  26. ALK2▲ 111×1 topic
  27. Clinical Practice Guidelines2▲ 5.3×4 topics
  28. Neuroblastoma2▲ 111×1 topic
  29. Ultrasound2▲ 27×2 topics
  30. BRAF Mutation2▲ 35×2 topics
  31. Molecular Characterization2▲ 14×4 topics
  32. Surgical Management2▲ 5.8×5 topics
  33. Differentiated Thyroid Cancer2▲ 59×1 topic
  34. Thyroid Nodules2▲ 59×1 topic
  35. Gastric Cancer2▲ 19×2 topics
  36. Cancer Treatment1▲ 7.7×4 topics
  37. Medical Ethics1▲ 13×3 topics
  38. Imatinib Mesylate1▲ 35×1 topic
  39. Palliative Care1▲ 11×2 topics
  40. Sunitinib1▲ 64×1 topic

Which research topics does European Neuroendocrine Tumor Society publish most on?

By volume in 2022–2025: Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Pancreatic and Hepatic Oncology Research and Neuroblastoma Research and Treatments.

Neuroendocrine Tumor Res…9Neuroendocrine Tumor Research Advances: 9 fractional worksLung Cancer Research Studies: 5 fractional worksPancreatic and Hepatic Oncology Research: 3 fractional worksNeuroblastoma Research and Treatments: 2 fractional worksThyroid Cancer Diagnosis…2Thyroid Cancer Diagnosis and Treatment: 2 fractional worksCell Image Analysis Techniques: 1 fractional worksGastrointestinal Tumor Research and Treatment: 1 fractional worksRadiopharmaceutical Chemistry and Applications: 1 fractional worksHepatocellular Carcinoma Treatment and Prognosis: 1 fractional worksPsychoanalysis and Psychopathology Research: 1 fractional works
EpidemiologyOncologyNeurologyEndocrinology, Diabetes and Metabolism5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Neuroendocrine Tumor Research Advances Epidemiology 9 works
  2. 2 Lung Cancer Research Studies Oncology 5 works
  3. 3 Pancreatic and Hepatic Oncology Research Oncology 3 works
  4. 4 Neuroblastoma Research and Treatments Neurology 2 works
  5. 5 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 2 works
  6. 6 Cell Image Analysis Techniques Biophysics 1 works
  7. 7 Gastrointestinal Tumor Research and Treatment Gastroenterology 1 works
  8. 8 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  9. 9 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 1 works
  10. 10 Psychoanalysis and Psychopathology Research Clinical Psychology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.7%not open61.3%

World: 28% of research is openly available.

with international co-authors36.2%domestic only63.8%

World: 19% is written across borders.

How has European Neuroendocrine Tumor Society's research output changed?

Output in 2018–2022 was 16% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Berlin

All research institutions in Berlin

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.